|
1
|
Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis.
|
Am J Respir Cell Mol Biol
|
2014
|
2.12
|
|
2
|
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2008
|
1.51
|
|
3
|
Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.
|
Am J Respir Cell Mol Biol
|
2007
|
1.29
|
|
4
|
MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.
|
Am J Respir Cell Mol Biol
|
2011
|
1.12
|
|
5
|
Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis.
|
Am J Pathol
|
2009
|
1.07
|
|
6
|
Resistin-like molecule α1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis.
|
Respir Res
|
2012
|
0.91
|
|
7
|
Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2014
|
0.83
|